These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 9395755)

  • 21. [Clinical applications of human interferon].
    Ghyka G; Moldovan I
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1987; 32(4):289-304. PubMed ID: 2450396
    [No Abstract]   [Full Text] [Related]  

  • 22. [Quality of life of patients with chronic hepatitis C: effect of treatments].
    Couzigou P
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B257-63. PubMed ID: 12180299
    [No Abstract]   [Full Text] [Related]  

  • 23. Interferon therapy.
    World Health Organ Tech Rep Ser; 1982; 676():1-28. PubMed ID: 6178225
    [No Abstract]   [Full Text] [Related]  

  • 24. Psychological screening before interferon therapy.
    Scalori A; Apale P; Roffi L
    Hepatology; 2001 Feb; 33(2):480. PubMed ID: 11172355
    [No Abstract]   [Full Text] [Related]  

  • 25. [Interferon].
    Steenhoek A
    Tijdschr Ziekenverpl; 1980 Aug; 33(16):768-70. PubMed ID: 6158137
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of chronic hepatitis C in sickle cell disease and thalassaemic patients with interferon and ribavirin.
    Ancel D; Amiot X; Chaslin-Ferbus D; Hagege I; Garioud A; Girot R; Pol S; Grange JD
    Eur J Gastroenterol Hepatol; 2009 Jul; 21(7):726-9. PubMed ID: 19404206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The interferons--Part 1.
    Freeman PR
    Am Pharm; 1994 May; NS34(5):24-6. PubMed ID: 7518644
    [No Abstract]   [Full Text] [Related]  

  • 28. Multiple fixed drug eruption with interferon/ribavirin combination therapy for hepatitis C virus infection.
    Sidhu-Malik NK; Kaplan AL
    J Drugs Dermatol; 2003 Oct; 2(5):570-3. PubMed ID: 14558408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Recent progress in the treatment of interferon-resistant hepatitis C].
    Kumada M
    Nihon Naika Gakkai Zasshi; 1999 Sep; 88(9):1759-62. PubMed ID: 10581760
    [No Abstract]   [Full Text] [Related]  

  • 30. Focus on hepatitis. Increased RBV dose for better HCV treatment response.
    Bernard EJ
    IAPAC Mon; 2006 Jan; 12(1):18. PubMed ID: 17249131
    [No Abstract]   [Full Text] [Related]  

  • 31. [Complications in interferon therapy for chronic hepatitis C].
    Arase Y
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):519-22. PubMed ID: 15359854
    [No Abstract]   [Full Text] [Related]  

  • 32. Future perspectives: towards interferon-free regimens for HCV.
    Gane E
    Antivir Ther; 2012; 17(6 Pt B):1201-10. PubMed ID: 23186654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferons.
    Balkwill FR
    Lancet; 1989 May; 1(8646):1060-3. PubMed ID: 2469921
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical significance of interferon therapy in treatments for hepatitis C virus-related hepatocellular carcinoma].
    Kubo S; Nishiguchi S; Hirohashi K; Tanaka H; Shuto T; Takemura S; Shiomi S; Kinoshita H
    Gan To Kagaku Ryoho; 2001 Dec; 28(13):1975-9. PubMed ID: 11791377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon, an antiviral drug for use in man.
    Myers M; Galasso G
    Tex Rep Biol Med; 1981-1982; 41():543-8. PubMed ID: 6189221
    [No Abstract]   [Full Text] [Related]  

  • 36. [Modern Russian Etiotropic Antiinfluenza Drugs].
    Ershov FI; Poloskov VV
    Antibiot Khimioter; 2014; 59(11-12):40-4. PubMed ID: 26448993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in interferon.
    Finter NB
    Practitioner; 1982 Oct; 226(1372):1729-34. PubMed ID: 6184707
    [No Abstract]   [Full Text] [Related]  

  • 38. Interferon as therapeutic agent.
    Borecký L; Fuchsberger N
    Acta Virol; 1983 Jul; 27(4):359-70. PubMed ID: 6195902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The dream for interferon.
    Baron S
    Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1294-300. PubMed ID: 7535725
    [No Abstract]   [Full Text] [Related]  

  • 40. [Interferon: validity, risks, prospects of clinical use].
    Rossi GB; Belardelli F
    Epidemiol Prev; 1987 Mar; 9(30):13-5. PubMed ID: 2466676
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.